https://pfdfamilyofcompanies.com/document/pfd-quarterly-report-2023-q2/ 2024-05-20T22:53:41+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/Screenshot-2024-05-20-182110.png https://pfdfamilyofcompanies.com/document/pfd-quarterly-report-2023-q1/ 2024-05-20T22:53:51+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/Screenshot-2024-05-20-181709.png https://pfdfamilyofcompanies.com/document/pfd-quarterly-report-2022-q4/ 2024-05-20T22:54:03+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/Screenshot-2024-05-20-181558.png https://pfdfamilyofcompanies.com/document/pfd-quarterly-report-2022-q3/ 2024-05-20T22:54:16+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/Screenshot-2024-05-20-181841.png https://pfdfamilyofcompanies.com/document/pfd-capital-project-navigator/ 2024-05-29T12:02:41+00:00 https://pfdfamilyofcompanies.com/document/pfd-quarterly-report-2023-q4/ 2024-06-05T18:53:33+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/Screenshot-2024-05-20-181939.png https://pfdfamilyofcompanies.com/document/pfd-capital-partners-inc-closes-on-purchase-of-regeneration-biomedical-inc-series-a-preferred-stock/ 2024-09-05T20:59:49+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/07/tree.png https://pfdfamilyofcompanies.com/document/pfd-ioi-launches-iknee-comfort-study-a-major-milestone-in-orthopedic-innovation/ 2024-09-05T21:01:35+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/09/Snip-PFD-iOI-Launches-iKnee-Comfort-Study-A-Major-Milestone-in-Orthopedic-Innovation-PFD-Family-Of-Companies-Brave.png https://pfdfamilyofcompanies.com/document/end-of-year-development-update-on-nkcs-huygens-proteus-technology/ 2025-06-03T23:23:42+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-122022-fi.jpg https://pfdfamilyofcompanies.com/document/2024-nkc-milestone-progress-update/ 2025-06-03T23:26:05+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-052024-fi.jpg https://pfdfamilyofcompanies.com/document/end-of-year-hhs-public-access-author-manuscript-recognition/ 2025-06-03T23:32:27+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-050922-fi.jpg https://pfdfamilyofcompanies.com/document/introducing-dr-daniel-rastein-cassdermarx-and-castle-irb/ 2025-06-04T05:19:39+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-030122-fi.jpg https://pfdfamilyofcompanies.com/document/introducing-the-iknee-resilient-arthroplasty-device-rad/ 2025-06-04T05:24:33+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-011823-fi.jpg https://pfdfamilyofcompanies.com/document/josh-shachar-to-speak-at-carnap-foundation-event-university-of-haifa-israel/ 2025-06-04T05:29:16+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-050223-fi.jpg https://pfdfamilyofcompanies.com/document/major-breakthrough-in-iknee-implant-manufacturing-process-announced-by-pfd-imed-2/ 2025-06-04T05:33:49+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-081523-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-iorthopedics-inc-achieves-breakthrough-in-iknee-implant-biocompatibility-testing-advancing-orthopedic-innovation/ 2025-06-04T05:41:05+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-120823-fi.jpg https://pfdfamilyofcompanies.com/document/nkc-announces-upcoming-animal-study-for-clinical-validation-of-its-huygens-proteus-robotic-arm-surgical-platform/ 2025-06-04T05:45:39+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-083022-fi.jpg https://pfdfamilyofcompanies.com/document/nkc-release-fourth-quarter-development-report-on-the-huygens-proteus-robotic-arm-surgical-platform/ 2025-06-04T05:51:09+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-111522-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-3001-nest-of-companies-art/ 2025-06-04T05:57:42+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-031422-fi.jpg https://pfdfamilyofcompanies.com/document/phase-1-development-of-huygens-smart-catheter-proteus-robotic-platform-completed/ 2025-06-04T06:03:23+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-031422-2-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-management-unveils-pfdpro-management-fund-at-del-mar-industry-day-showcasing-innovation-in-healthcare-financing/ 2025-06-04T06:13:12+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-072823-fi.jpg https://pfdfamilyofcompanies.com/document/third-quarter-development-report-on-the-huygens-proteus-technology/ 2025-06-04T06:25:36+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-102723-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-quarterly-report-2023-q3/ 2025-06-04T06:30:08+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/Screenshot-2024-05-20-182315.png https://pfdfamilyofcompanies.com/document/pfd-announcwes-regeneration-biomedical-as-a-portfolio-company-in-upcoming-hybrid-medical-receivables-fund/ 2025-06-20T21:37:08+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/06/pfd-pr-062025-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-has-completed-relocation-to-its-new-irvine-headquarters/ 2025-06-25T20:18:57+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/06/pfd-pr-062525-fi.jpg https://pfdfamilyofcompanies.com/document/rbis-president-and-founder-presents-breakthrough-stem-cell-therapy-for-cns-disorders/ 2025-07-17T01:18:58+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/06/pfd-pr-062325-fi.jpg https://pfdfamilyofcompanies.com/document/stanley-otake-named-lead-consultant-for-medical-receivables-acquisition-diligence-and-portfolio-servicing/ 2025-08-23T05:34:48+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/08/pfd-pr-082225-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-capital-partners-announces-that-regeneration-biomedical-has-applied-for-phase-iia-clinical-trial/ 2025-08-29T22:41:31+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/08/pfd-pr-082825-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-capital-partners-announces-the-close-of-both-its-pfdselect-medical-receivables-1014-and-1015-offerings/ 2025-10-16T19:22:25+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/10/pfd-pr-101625-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-capital-partners-announces-the-departure-of-team-member-jim-bradford/ 2025-10-17T06:00:23+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/10/pfd-pr-101725-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-capital-partners-announces-25-million-commitment-to-regeneration-biomedical-following-octane-medical-innovation-award/ 2025-11-11T07:54:09+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/11/pfd-pr111025-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-capital-partners-congratulates-dr-christopher-woodson-on-completion-of-his-1000th-mako-smartrobotics-joint-replacement/ 2025-12-04T19:56:35+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/12/pfd-pr-120225-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-announces-that-cassderma-rx-has-received-fda-preliminary-clearance-to-advance-directly-into-phase-2-clinical-trials-pending-completion-of-glp-toxicology-and-gmp-ingredient-studies/ 2025-12-20T01:11:31+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/12/pfd-pr-121925-fi.jpg https://pfdfamilyofcompanies.com/document/notice-of-name-conflict-in-search-engine-results-to-our-investor-family/ 2026-01-03T00:24:10+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/08/pfd-in-070825-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-mf1008-now-closed/ 2026-01-03T00:47:43+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-032824-fi.jpg https://pfdfamilyofcompanies.com/document/pfdselect-medical-receivables-1013-llc-has-officially-closed-to-new-investors/ 2026-01-03T00:48:07+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/06/pfd-pr-052725-fi.jpg https://pfdfamilyofcompanies.com/document/announcing-pfd-pro-management-opportunity-fund/ 2026-01-03T00:48:38+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2024/05/pfd-pr-101923-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-q1-2026-investor-webinar-announcement/ 2026-01-03T00:59:27+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/08/pfd-in-070825-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-investor-access-for-notices-and-reports/ 2026-01-15T01:38:33+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/08/pfd-in-070825-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-announces-the-u-s-patent-office-has-granted-regeneration-biomedical-inc-a-new-patent-for-its-cerewint-technology-platform/ 2026-03-17T05:25:11+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2026/03/pfd-pr-031726-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-announces-launch-of-three-new-special-purpose-entities/ 2026-03-17T17:45:48+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/08/pfd-in-070825-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-provides-update-on-2025-schedule-k-1-reporting/ 2026-03-21T19:06:26+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/08/pfd-in-070825-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-provides-update-on-ira-k-1s-and-ubit/ 2026-04-09T06:50:31+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2025/08/pfd-in-070825-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-capital-partners-announces-contribution-to-support-iowa-community-following-egg-production-facility-fire/ 2026-04-13T06:19:32+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2026/04/pfd-press-release-fi-041226.jpg https://pfdfamilyofcompanies.com/document/pfd-capital-partners-announces-closing-of-pfdselect-medical-receivables-1018-llc/ 2026-06-13T18:31:33+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2026/06/pfd-pr-061026-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-highlights-regeneration-biomedicals-presentation-at-isct-2026-annual-meeting/ 2026-06-13T18:32:18+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2026/06/pfd-pr-061426-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-announces-regeneration-biomedicals-fda-fast-track-designation-and-phase-iia-trial-site-selections/ 2026-06-22T19:32:00+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2026/06/pfd-pr-062126-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-highlights-dr-daniel-rasteins-invitation-to-participate-in-fda-patient-focused-drug-development-meeting-on-nonhealing-chronic-wounds/ 2026-06-28T22:31:11+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2026/06/pfd-pr-062826-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-announces-july-31-first-in-human-implantation-of-the-iknee/ 2026-07-29T18:04:34+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2026/07/pfd-pr-072826-fi.jpg https://pfdfamilyofcompanies.com/document/pfd-annouces-completion-of-the-first-in-human-iknee-implantation/ 2026-08-25T02:27:50+00:00 https://pfdfamilyofcompanies.com/wp-content/uploads/2026/08/pfd-pr-fi-template-082426-scaled.jpg